Saturday, July 11, 2026

Drug profile · INN

granisetron product

granisetron product (KYTRIL) is a serotonin 3a (5-ht3a) receptor antagonist.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — granisetron product
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

granisetron product (KYTRIL) is a serotonin 3a (5-ht3a) receptor antagonist.

Key facts

INN granisetron product
Brand KYTRIL
Mechanism Serotonin 3a (5-HT3a) receptor antagonist
Target 5-hydroxytryptamine receptor 3A

Mechanism of action

Serotonin 3a (5-HT3a) receptor antagonist

Primary target: 5-hydroxytryptamine receptor 3A

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. alosetron hydrochloride Serotonin 3a (5-HT3a) receptor antagonist
  2. granisetron Alimentary tract and metabolism (A04)
  3. granisetron hydrochloride Serotonin 3a (5-HT3a) receptor antagonist
  4. ondansetron Serotonin 3a (5-HT3a) receptor antagonist
  5. ondansetron hydrochloride Serotonin 3a (5-HT3a) receptor antagonist
  6. palonosetron hydrochloride Serotonin 3a (5-HT3a) receptor antagonist

Frequently asked questions

What is granisetron product?

granisetron product (KYTRIL) is a serotonin 3a (5-ht3a) receptor antagonist.

What is the brand name for granisetron product?

KYTRIL is a marketed brand name for granisetron product. Check FDA Drugs@FDA for the current US label holder and prescribing information.